{
    "medicine_id": "c89bd7b5b419b62053aa301d4ccc7206fe0de147",
    "platform_id": "DB00102",
    "metadata": {
        "name": "Regranex 0 01 Gel",
        "composition": "0 01 Becaplermin",
        "clinical_particulars": {
            "therapeutic_indications": "For topical treatment of skin ulcers from diabetes",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Used for the topical treatment of skin ulcers Regranex has a biological activity similar to that of endogenous platelet derived growth factor which includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair and enhancing the formation of granulation tissue",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}